You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 3, 2025

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
Published on: June 15, 2012
Jon F Edd1,2, Avanish Mishra1,2,3, Kyle C Smith4
1BioMEMS Resource Center, Center for Engineering in Medicine and Surgical Services, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Isolating rare circulating tumor cells (CTCs) from blood is crucial for personalized cancer treatment. Advanced microfluidic technologies offer high-throughput methods for pure CTC isolation, overcoming challenges like EpCAM absence.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: